{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,20]],"date-time":"2026-08-20T16:19:09Z","timestamp":1787242749199,"version":"build-2736575974"},"reference-count":37,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"47","license":[{"start":{"date-parts":[[2025,11,21]],"date-time":"2025-11-21T00:00:00Z","timestamp":1763683200000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2025,11,21]]},"abstract":"<jats:p>\n                    Guillain\u2013Barr\u00e9 syndrome (GBS) is a rare but serious neurological disorder that often leads to significant morbidity and mortality. This study aimed to investigate the clinical characteristics, epidemiological trends, and outcomes of GBS patients admitted to Jimma Medical Center (JMC). This was a mixed retrospective and prospective study conducted at JMC, a tertiary teaching hospital in southwest Ethiopia. Medical records of patients admitted with GBS from October 2017 to August 2021 were retrospectively reviewed, while patients admitted between September 2021 and October 2024 were prospectively recruited. Data were collected on socio-demographic information, clinical presentation, diagnostic tests, treatment, and discharge outcomes. Descriptive statistics, Kaplan\u2013Meier survival analysis, and Geographic Information System mapping were used to analyze the data. A total of 93 patients with GBS were admitted during the 7 year study period. The median age was 30 years (IQR: 23\u201340), and most patients (54.8%) were within the 15 to 30 age group. Admissions peaked between November and January each year, with notable increase since the end of 2021. Among the 54 patients with complete medical records, the most common presenting symptoms were extremity weakness (92.6%) and difficulty walking (59.3%), while ascending paralysis was observed in 70.4% of cases. Bulbar symptoms occurred in 31.5% of patients. Preceding infections, particularly flu-like symptoms, were reported by 46.3% of them. Overall, 77.8% required ICU care, with 42.6% needing mechanical ventilation. Intravenous immunoglobulin therapy was administered to only 14.8% of patients. The in-hospital mortality rate was 25.9%, and complications such as quadriplegia (46.3%) and depression (35.2%) were common. Patients who required mechanical ventilation faced a significantly higher risk of mortality (\n                    <jats:italic toggle=\"yes\">P<\/jats:italic>\n                    \u2005&lt;\u2005.05), with survival rates dropping to 0% by day 165 in this group. This study highlights a significant burden of GBS at JMC, with notable seasonal trends, high ICU admission rates, and substantial mortality. Early diagnoses, improved access to immunotherapy, and enhanced supportive care, especially for those with respiratory failure, are critical to improving outcomes. The findings underscore the need for robust public health strategies to prevent, manage, and mitigate the impact of GBS, particularly in low-resource settings like Ethiopia.\n                  <\/jats:p>","DOI":"10.1097\/md.0000000000046232","type":"journal-article","created":{"date-parts":[[2025,11,26]],"date-time":"2025-11-26T15:02:43Z","timestamp":1764169363000},"page":"e46232","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":1,"title":["Clinical characteristics, temporal patterns, and outcomes of Guillain\u2013Barr\u00e9 syndrome: A 7-year cross-sectional study in a low-resource setting"],"prefix":"10.1097","volume":"104","author":[{"given":"Tamirat Godebo","family":"Woyimo","sequence":"first","affiliation":[{"name":"Department of Internal Medicine, Jimma University, Jimma, Oromia, Ethiopia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9030-4328","authenticated-orcid":false,"given":"Eyob Girma","family":"Abera","sequence":"additional","affiliation":[{"name":"Department of Public Health, Jimma University, Jimma, Oromia, Ethiopia"},{"name":"Jimma University Clinical Trial Unit, Jimma, Oromia, Ethiopia."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meti Mulatu","family":"Kenea","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Jimma University, Jimma, Oromia, Ethiopia"},{"name":"Jimma University Clinical Trial Unit, Jimma, Oromia, Ethiopia."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Addisalem Gebresilase","family":"Hailemariam","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Jimma University, Jimma, Oromia, Ethiopia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Geda Chana","family":"Hotessa","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Jimma University, Jimma, Oromia, Ethiopia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Esayas Kebede","family":"Gudina","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Jimma University, Jimma, Oromia, Ethiopia"},{"name":"Jimma University Clinical Trial Unit, Jimma, Oromia, Ethiopia."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-20260514","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1007\/978-1-4614-6567-6_28","article-title":"Guillain-Barr\u00e9 syndrome and related disorders.","author":"Piccione","year":"2014","journal-title":"Neuromuscular disorders in clinical practice"},{"key":"R2-20260514","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/j.jcrc.2018.01.016","article-title":"Characteristics, incidence and outcome of patients admitted to intensive care unit with Guillain-Barre syndrome in Australia and New Zealand.","volume":"45","author":"Ancona","year":"2018","journal-title":"J Crit Care"},{"key":"R3-20260514","doi-asserted-by":"crossref","first-page":"14222","DOI":"10.3390\/ijms232214222","article-title":"Triggers of Guillain\u2013Barr\u00e9 syndrome: campylobacter jejuni predominates.","volume":"23","author":"Finsterer","year":"2022","journal-title":"Int J Mol Sci"},{"key":"R4-20260514","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1007\/s12016-010-8213-3","article-title":"Guillain\u2013Barr\u00e9 syndrome\u2014a classical autoimmune disease triggered by infection or vaccination.","volume":"42","author":"Israeli","year":"2012","journal-title":"Clin Rev Allergy Immunol"},{"key":"R5-20260514","doi-asserted-by":"crossref","first-page":"3773","DOI":"10.1038\/s41598-023-30940-1","article-title":"Real-world data on the incidence and risk of Guillain\u2013Barr\u00e9 syndrome following SARS-CoV-2 vaccination: a prospective surveillance study.","volume":"13","author":"Ha","year":"2023","journal-title":"Sci Rep"},{"key":"R6-20260514","doi-asserted-by":"crossref","first-page":"1461","DOI":"10.1016\/S0140-6736(12)62189-8","article-title":"Association between Guillain-Barr\u00e9 syndrome and influenza A (H1N1) 2009 monovalent inactivated vaccines in the USA: a meta-analysis.","volume":"381","author":"Salmon","year":"2013","journal-title":"Lancet"},{"key":"R7-20260514","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1007\/s10654-019-00596-1","article-title":"Vaccines and the risk of Guillain-Barr\u00e9 syndrome.","volume":"35","author":"Chen","year":"2020","journal-title":"Eur J Epidemiol"},{"key":"R8-20260514","doi-asserted-by":"crossref","first-page":"907","DOI":"10.3390\/jcm12030907","article-title":"The peculiarity of infection and immunity correlated with Guillain-Barre syndrome in the HIV-infected population.","volume":"12","author":"Wang","year":"2023","journal-title":"J Clin Med"},{"key":"R9-20260514","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1097\/CND.0b013e31815afaac","article-title":"HIV infection presenting with motor axonal variant of Guillain-Barr\u00e9 syndrome.","volume":"9","author":"Wagner","year":"2007","journal-title":"J Clin Neuromuscul Dis"},{"key":"R11-20260514","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1038\/nrneurol.2014.121","article-title":"Guillain\u2013Barr\u00e9 syndrome: pathogenesis, diagnosis, treatment and prognosis.","volume":"10","author":"Van den Berg","year":"2014","journal-title":"Nat Rev Neurol"},{"key":"R12-20260514","doi-asserted-by":"crossref","first-page":"e193","DOI":"10.1016\/j.lpm.2013.02.328","article-title":"Diagnosis, treatment and prognosis of Guillain-Barr\u00e9 syndrome (GBS).","volume":"42","author":"van Doorn","year":"2013","journal-title":"Presse Med"},{"key":"R13-20260514","doi-asserted-by":"crossref","first-page":"15520","DOI":"10.1038\/s41598-024-65265-0","article-title":"A retrospective analysis of the clinical profile and factors associated with mortality and poor hospital outcomes in adult Guillain\u2013Barre syndrome patients.","volume":"14","author":"Tewedaj","year":"2024","journal-title":"Sci Rep"},{"key":"R14-20260514","first-page":"73","article-title":"Assessing the predictors and outcomes of Guillain-Barr\u00e9 syndrome at St. Paul\u2019s and Zewditu hospitals in Addis Ababa, Ethiopia.","volume":"3","author":"Teshome","year":"2022","journal-title":"Am J Nurs Heal Sci"},{"key":"R15-20260514","first-page":"21","article-title":"Guillain-Barr\u00e9 syndrome in Ethiopian patients.","volume":"43","author":"Melaku","year":"2005","journal-title":"Ethiop Med J"},{"key":"R17-20260514","doi-asserted-by":"crossref","first-page":"S21","DOI":"10.1002\/ana.410270707","article-title":"Assessment of current diagnostic criteria for Guillain\u2010Barr\u00e9 syndrome.","volume":"27","author":"Asbury","year":"1990","journal-title":"Ann Neurol"},{"key":"R18-20260514","doi-asserted-by":"crossref","first-page":"1115","DOI":"10.1093\/brain\/109.6.1115","article-title":"An acute axonal form of guillain-barr\u00e9e polyneuropathy.","volume":"109 (Pt 6)","author":"Feasby","year":"1986","journal-title":"Brain"},{"key":"R19-20260514","first-page":"14","article-title":"Traumatic quadriplegia, a comprehensive review.","volume":"37","author":"O\u2019Connor","year":"1971","journal-title":"J Rehabil"},{"key":"R21-20260514","doi-asserted-by":"crossref","first-page":"750","DOI":"10.1016\/S0140-6736(78)92644-2","article-title":"Controlled trial of prednisolone in acute polyneuropathy.","volume":"312","author":"Hughes","year":"1978","journal-title":"Lancet"},{"key":"R22-20260514","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1136\/jnnp.55.3.181","article-title":"Accuracy of clinical diagnosis of idiopathic Parkinson\u2019s disease: a clinico-pathological study of 100 cases.","volume":"55","author":"Hughes","year":"1992","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"R24-20260514","doi-asserted-by":"crossref","first-page":"23","DOI":"10.4236\/nm.2013.41004","article-title":"Seasonal, age & gender variation of Guillain Barre syndrome in a tertiary referral center in India.","volume":"4","author":"Sharma","year":"2013","journal-title":"Neurosci Med"},{"key":"R25-20260514","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/j.jns.2013.09.002","article-title":"Clinico-electrophysiological profile and predictors of functional outcome in Guillain\u2013Barre syndrome (GBS).","volume":"335","author":"Verma","year":"2013","journal-title":"J Neurol Sci"},{"key":"R26-20260514","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1186\/s41983-023-00764-x","article-title":"Seroprevalence of Campylobacter jejuni infection in common subtypes of Guillain\u2013Barre syndrome in Kashmiri population.","volume":"59","author":"Mir","year":"2023","journal-title":"Egypt J Neurol Psychiatry Neurosurg"},{"key":"R28-20260514","first-page":"369","article-title":"Guillain\u2013Barre syndrome: demographics, clinical features, and outcome in a single tertiary care hospital, Oman.","volume":"25","author":"Al Maawali","year":"2020","journal-title":"Neurosci J"},{"key":"R29-20260514","doi-asserted-by":"crossref","first-page":"e2386","DOI":"10.1212\/WNL.0000000000207282","article-title":"CSF Findings in relation to clinical characteristics, subtype, and disease course in patients with Guillain-Barr\u00e9 syndrome.","volume":"100","author":"Al-Hakem","year":"2023","journal-title":"Neurology"},{"key":"R30-20260514","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1086\/594124","article-title":"Guillain-Barr\u00e9 syndrome and influenza virus infection.","volume":"48","author":"Sivadon-Tardy","year":"2009","journal-title":"Clin Infect Dis"},{"key":"R31-20260514","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12879-020-4827-0","article-title":"Burden and seasonality of medically attended influenza like illness (ILI) in Ethiopia, 2012 to 2017.","volume":"20","author":"Tadesse","year":"2020","journal-title":"BMC Infect Dis"},{"key":"R32-20260514","doi-asserted-by":"crossref","first-page":"3389","DOI":"10.1111\/ene.15516","article-title":"Guillain\u2013Barr\u00e9 syndrome following influenza vaccination: a 15\u2010year nationwide population\u2010based case\u2013control study.","volume":"29","author":"Levison","year":"2022","journal-title":"Eur J Neurol"},{"key":"R33-20260514","doi-asserted-by":"crossref","first-page":"150","DOI":"10.3390\/vaccines8020150","article-title":"Is an increased risk of developing Guillain\u2013Barr\u00e9 syndrome associated with seasonal influenza vaccination? A systematic review and meta-analysis.","volume":"8","author":"Petr\u00e1\u0161","year":"2020","journal-title":"Vaccines"},{"key":"R34-20260514","doi-asserted-by":"crossref","first-page":"e2232571","DOI":"10.1001\/jamanetworkopen.2022.32571","article-title":"Risk of Guillain-Barr\u00e9 syndrome among older adults receiving influenza vaccine in Taiwan.","volume":"5","author":"Yen","year":"2022","journal-title":"JAMA Netw Open"},{"key":"R36-20260514","doi-asserted-by":"crossref","first-page":"908","DOI":"10.1186\/s12879-024-09836-6","article-title":"Clinical profiles and mortality predictors of hospitalized patients with COVID-19 in Ethiopia.","volume":"24","author":"Abera","year":"2024","journal-title":"BMC Infect Dis"},{"key":"R37-20260514","doi-asserted-by":"crossref","first-page":"100578","DOI":"10.1016\/j.bbih.2022.100578","article-title":"Guillain\u2013Barr\u00e9 syndrome associated with COVID-19: a systematic review.","volume":"28","author":"Pimentel","year":"2023","journal-title":"Brain Behav Immun Health"},{"key":"R38-20260514","doi-asserted-by":"crossref","first-page":"5586","DOI":"10.1038\/s41598-023-32501-y","article-title":"Priority age targets for COVID-19 vaccination in Ethiopia under limited vaccine supply.","volume":"13","author":"Galli","year":"2023","journal-title":"Sci Rep"},{"key":"R39-20260514","doi-asserted-by":"crossref","first-page":"3358","DOI":"10.1111\/ene.15497","article-title":"Guillain-Barr\u00e9 syndrome and COVID\u201019: a 1-year observational multicenter study.","volume":"29","author":"Filosto","year":"2022","journal-title":"Eur J Neurol"},{"key":"R40-20260514","doi-asserted-by":"crossref","first-page":"e236182","DOI":"10.1136\/bcr-2020-236182","article-title":"Guillain-Barr\u00e9 syndrome following COVID-19: a newly emerging post-infectious complication.","volume":"13","author":"Webb","year":"2020","journal-title":"BMJ Case Rep"},{"key":"R41-20260514","doi-asserted-by":"crossref","first-page":"q488","DOI":"10.1136\/bmj.q488","article-title":"Covid-19: two rare vaccine side effects detected in large global study.","volume":"384","author":"Wise","year":"2024","journal-title":"BMJ"},{"key":"R44-20260514","doi-asserted-by":"crossref","first-page":"e2094","DOI":"10.1212\/WNL.0000000000207847","article-title":"Risk of Guillain-Barr\u00e9 syndrome following COVID-19 vaccines: a nationwide self-controlled case series study.","volume":"101","author":"Le Vu","year":"2023","journal-title":"Neurology"},{"key":"R47-20260514","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1038\/s41582-021-00467-y","article-title":"Guillain\u2013Barr\u00e9 syndrome in low-income and middle-income countries: challenges and prospects.","volume":"17","author":"Papri","year":"2021","journal-title":"Nat Rev Neurol"}],"container-title":["Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000046232","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,14]],"date-time":"2026-05-14T11:06:46Z","timestamp":1778756806000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000046232"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,21]]},"references-count":37,"journal-issue":{"issue":"47","published-print":{"date-parts":[[2025]]}},"URL":"https:\/\/doi.org\/10.1097\/md.0000000000046232","relation":{},"ISSN":["0025-7974","1536-5964"],"issn-type":[{"value":"0025-7974","type":"print"},{"value":"1536-5964","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,11,21]]},"assertion":[{"value":"2025-02-04","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-10-21","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}